Ausgabe 3/2005
Inhalt (22 Artikel)
Facing the enigma of immunomodulatory effects of intravenous immunoglobulin
Tal Sapir, Yehuda Shoenfeld
Intravenous immunoglobulin and dendritic cells
Namita Misra, Jagadeesh Bayary, Sooryasarathi Dasgupta, Amal Ephrem, Jean-Paul Duong Van Huyen, Sandrine Delignat, Gazzala Hassan, Giuseppina Caligiuri, Antonino Nicoletti, Sebastien Lacroix-Desmazes, Michel D. Kazatchkine, Srini V. Kaveri
Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation
Hans U. Lutz, Peter J. Späth
Toward molecular targeting with specific intravenous immunoglobulin preparation
Miri Blank, Israel Nur, Orgad Toub, Anabel Maor, Yehuda Shoenfeld
Intravenous immunoglobulin therapy and systemic lupus erythematosus
Gisele Zandman-Goddard, Yair Levy, Yehuda Shoenfeld
Intravenous immunoglobulin therapy in vasculitis
Peer Malte Aries, Bernhard Hellmich, Wolfgang Ludwig Gross
Intravenous immunoglobulin for treatment of pemphigus
Lehavit Akerman, Daniel Mimouni, Michael David
Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy
Tal Sapir, Yehuda Shoenfeld
Intravenous immunoglobulin and atherosclerosis
Eiji Matsuura, Kazuko Kobayashi, Katsumi Inoue, Yehuda Shoenfeld
Intravenous immunoglobulin and recurrent pregnancy loss
Howard J. A. Carp, Tal Sapir, Yehuda Shoenfeld
Virus safety of intravenous immunoglobulin
Nicola Boschetti, Martin Stucki, Peter J. Späth, Christoph Kempf